BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36148820)

  • 21. Haplotype analysis of SERPINE1 gene: Risk for aneurysmal subarachnoid hemorrhage and clinical outcomes.
    Lin M; Griessenauer CJ; Starke RM; Tubbs RS; Shoja MM; Foreman PM; Vyas NA; Walters BC; Harrigan MR; Hendrix P; Fisher WS; Pittet JF; Mathru M; Lipsky RH
    Mol Genet Genomic Med; 2019 Aug; 7(8):e737. PubMed ID: 31268630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E polymorphism in aneurysmal subarachnoid haemorrhage in West Sweden.
    Csajbok LZ; Nylén K; Öst M; Blennow K; Zetterberg H; Nellgård P; Nellgård B
    Acta Neurol Scand; 2016 Jun; 133(6):466-74. PubMed ID: 26374096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Level and course of FEV1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general population.
    Siedlinski M; Postma DS; Boer JM; van der Steege G; Schouten JP; Smit HA; Boezen HM
    Respir Res; 2009 Aug; 10(1):73. PubMed ID: 19671143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Common variants of NFE2L2 gene predisposes to acute respiratory distress syndrome in patients with severe sepsis.
    Acosta-Herrera M; Pino-Yanes M; Blanco J; Ballesteros JC; Ambrós A; Corrales A; Gandía F; Subirá C; Domínguez D; Baluja A; Añón JM; Adalia R; Pérez-Méndez L; Flores C; Villar J;
    Crit Care; 2015 Jun; 19(1):256. PubMed ID: 26077880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of factor XIIIA promoter methylation status in aneurysmal subarachnoid haemorrhage (aSAH).
    Arati S; Chetan GK; Sibin MK; Bhat DI; Vazhayil V; Narasingarao KVL
    BMC Cardiovasc Disord; 2019 Jul; 19(1):170. PubMed ID: 31315570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional Polymorphism in the
    Ji G; Zhang M; Liu Q; Wu S; Wang Y; Chen G; Sandford AJ; He JQ
    Front Immunol; 2021; 12():660384. PubMed ID: 34108963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ryanodine Receptor 1 Polymorphism Is Not Associated with Aneurysmal Subarachnoid Hemorrhage or its Clinical Sequelae.
    Hendrix P; Foreman PM; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Lin M; Walters BC; Tubbs RS; Shoja MM; Pittet JF; Mathru M; Griessenauer CJ
    World Neurosurg; 2017 Apr; 100():190-194. PubMed ID: 28087430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphism and plasma levels of apolipoprotein E and the risk of aneurysmal subarachnoid hemorrhage in a Chinese population: a case-control study.
    Liu X; Zhan W; Wu Q; Wang F; Yang B; Ou Q
    Lipids Health Dis; 2018 May; 17(1):115. PubMed ID: 29769126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Association of a Single-Nucleotide Polymorphism in the Nuclear Factor (Erythroid-Derived 2)-Like 2 Gene With Adverse Drug Reactions, Multimorbidity, and Frailty in Older People.
    Scutt G; Overall A; Bakrania P; Krasteva E; Parekh N; Ali K; Davies JG; Rajkumar C
    J Gerontol A Biol Sci Med Sci; 2020 May; 75(6):1050-1057. PubMed ID: 31102514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Plasminogen Activator Inhibitor 1 (SERPINE1) Polymorphisms and Aneurysmal Subarachnoid Hemorrhage.
    Hendrix P; Foreman PM; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Lin M; Walters BC; Tubbs RS; Shoja MM; Pittet JF; Mathru M; Griessenauer CJ
    World Neurosurg; 2017 Sep; 105():672-677. PubMed ID: 28599907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin 6-174G>C polymorphism and risk of aneurysmal subarachnoid hemorrhage: case-control study and meta-analysis.
    Pera J; Dziedzic T; Adamski M; Jagiella J; Krupa M; Moskala M; Szczudlik A; Slowik A
    Acta Neurol Scand; 2012 Feb; 125(2):111-5. PubMed ID: 21410438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NFE2L2 polymorphisms, mortality, and metabolism in the general population.
    Figarska SM; Vonk JM; Boezen HM
    Physiol Genomics; 2014 Jun; 46(12):411-7. PubMed ID: 24790085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Genome-Wide Association Study of Outcome After Aneurysmal Subarachnoid Haemorrhage: Discovery Analysis.
    Gaastra B; Alexander S; Bakker MK; Bhagat H; Bijlenga P; Blackburn SL; Collins MK; Doré S; Griessenauer CJ; Hendrix P; Hong EP; Hostettler IC; Houlden H; IIhara K; Jeon JP; Kim BJ; Li J; Morel S; Nyquist P; Ren D; Ruigrok YM; Werring D; Tapper W; Galea I; Bulters D
    Transl Stroke Res; 2023 Oct; 14(5):681-687. PubMed ID: 36264420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of endothelial nitric oxide synthase -786 T/C polymorphism in cardiac instability following aneurysmal subarachnoid hemorrhage.
    Hendrix P; Foreman PM; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Lin M; Walters BC; Tubbs RS; Shoja MM; Pittet JF; Mathru M; Griessenauer CJ
    Nitric Oxide; 2017 Dec; 71():52-56. PubMed ID: 29079038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of outcome after aneurysmal subarachnoid haemorrhage using data from patient admission.
    Rubbert C; Patil KR; Beseoglu K; Mathys C; May R; Kaschner MG; Sigl B; Teichert NA; Boos J; Turowski B; Caspers J
    Eur Radiol; 2018 Dec; 28(12):4949-4958. PubMed ID: 29948072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutrophil-to-lymphocyte ratio as an independent predictor for unfavorable functional outcome in aneurysmal subarachnoid hemorrhage.
    Giede-Jeppe A; Reichl J; Sprügel MI; Lücking H; Hoelter P; Eyüpoglu IY; Kuramatsu JB; Huttner HB; Gerner ST
    J Neurosurg; 2019 Feb; 132(2):400-407. PubMed ID: 30717052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial nitric oxide synthase tagging single nucleotide polymorphisms and recovery from aneurysmal subarachnoid hemorrhage.
    Alexander S; Poloyac S; Hoffman L; Gallek M; Dianxu Ren ; Balzer J; Kassam A; Conley Y
    Biol Res Nurs; 2009 Jul; 11(1):42-52. PubMed ID: 19419976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Apolipoprotein E Genotypes in Aneurysmal Subarachnoid Hemorrhage: Susceptibility, Complications, and Prognosis.
    Hu X; Xie Z; Zan X; Ma L; Li H; You C; Jiang Y
    World Neurosurg; 2018 Oct; 118():e666-e676. PubMed ID: 30010064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical arterial abnormalities and outcome after aneurysmal subarachnoid haemorrhage: A pilot cohort study.
    Gakuba C; Hanouz JL; Abadie C; Gaberel T; Braud F; Courthéoux P; Touzé E; Labeyrie PE
    Anaesth Crit Care Pain Med; 2020 Dec; 39(6):832-836. PubMed ID: 32777435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological Modulations of Nrf2 and Therapeutic Implications in Aneurysmal Subarachnoid Hemorrhage.
    Zhang Q; Zhang J; Mo J
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.